Completed PHASE4 INTERVENTIONAL NCT00175240

Enhancing the Secondary Prevention of Coronary Artery Disease

Enhancing the Use of Secondary Prevention Strategies in Patients With Coronary Artery Disease (The ESP-CAD Study)

Sponsor: Alberta Heritage Foundation for Medical Research

Conditions Coronary Disease Ischemic Heart Disease

Interventions Evidence summaries endorsed by local opinion leaders

Updated 5 times since 2017 Last updated: Jul 25, 2015 Started: Mar 31, 2005 Primary completion: Aug 31, 2011 Completion: Jul 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Coronary Disease and Ischemic Heart Disease, this trial is completed. The trial is conducted by Alberta Heritage Foundation for Medical Research and has accumulated 5 data snapshots since 2005. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Mar 2005

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Alberta Heritage Foundation for Medical Research
Heart and Stroke Foundation of Canada
Pfizer
University of Alberta

Data source: University of Alberta

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Edmonton, Canada